Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination.

Emerging Microbes & Infections
Yuxin ChenChao Wu

Abstract

Global concerns arose as the emerged and rapidly spreading SARS-CoV-2 variants might escape host immunity induced by vaccination. In this study, a heterologous prime-boost immunization strategy for COVID-19 was designed to prime with a DNA vaccine encoding wild type (WT) spike protein receptor-binding domain (RBD) followed by S1 protein-based vaccine in rabbits. Four vaccine-elicited rabbit monoclonal antibodies (RmAbs), including 1H1, 9H1, 7G5, and 5E1, were isolated for biophysical property, neutralization potency and sequence analysis. All RmAbs recognized RBD or S1 protein with KD in the low nM or sub nM range. 1H1 and 9H1, but neither 7G5 nor 5E1, can bind to all RBD protein variants derived from B.1.351. All four RmAbs were able to neutralize wild type (WT) SARS-CoV-2 strain in pseudovirus assay, and 1H1 and 9H1 could neutralize the SARS-CoV-2 WT authentic virus with IC50 values of 0.136 and 0.026 μg/mL, respectively. Notably, 1H1 was able to neutralize all 6 emerging SARS-CoV-2 variants tested including D614G, B.1.1.7, B.1.429, P.1, B.1.526, and B.1.351 variants, and 5E1 could neutralize against the above 5 variants except P.1. Epitope binning analysis revealed that 9H1, 5E1 and 1H1 recognized distinct epitopes, while 9H...Continue Reading

References

Nov 4, 2008·Nucleic Acids Research·Marie-Paule LefrancPatrice Duroux
Mar 27, 2012·Nature Biotechnology·Wan Cheung CheungRoberto D Polakiewicz
Nov 8, 2014·Nucleic Acids Research·Marie-Paule LefrancSofia Kossida
May 23, 2015·Nature Reviews. Cancer·George J Weiner
Jan 1, 2014·Vaccines·Yuxin ChenShan Lu
Mar 8, 2018·The New England Journal of Medicine·Hilary D MarstonAnthony S Fauci
Nov 27, 2019·Drugs·Anthony Markham
Nov 28, 2019·The New England Journal of Medicine·Sabue MulanguUNKNOWN PALM Consortium Study Team
Mar 25, 2020·Emerging Microbes & Infections·Jianhui NieYouchun Wang
Jun 10, 2020·Science Translational Medicine·Supriya RavichandranSurender Khurana
Jun 20, 2020·Nature·Davide F RobbianiMichel C Nussenzweig
Jun 28, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Wafaa B AlsoussiAli H Ellebedy
Oct 1, 2020·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Ruiyin ChuRachel Palmer
Oct 8, 2020·BioRxiv : the Preprint Server for Biology·Yixuan J HouRalph S Baric
Oct 29, 2020·The New England Journal of Medicine·Peter ChenUNKNOWN BLAZE-1 Investigators
Jan 28, 2021·BioRxiv : the Preprint Server for Biology·Constantinos Kurt WibmerPenny L Moore
Feb 4, 2021·BioRxiv : the Preprint Server for Biology·Xuping XiePei-Yong Shi
Feb 4, 2021·BioRxiv : the Preprint Server for Biology·Pengfei WangDavid D Ho
Feb 24, 2021·MedRxiv : the Preprint Server for Health Sciences·Wilfredo F Garcia-BeltranAlejandro B Balazs
Mar 4, 2021·Nature Medicine·Constantinos Kurt WibmerPenny L Moore
Mar 5, 2021·Science·Nicholas G DaviesW John Edmunds
Mar 9, 2021·Nature·Pengfei WangDavid D Ho
Mar 11, 2021·BioRxiv : the Preprint Server for Biology·Pengfei WangDavid D Ho
Mar 21, 2021·Cell·Wilfredo F Garcia-BeltranAlejandro B Balazs
Mar 28, 2021·Nature Medicine·Delphine PlanasOlivier Schwartz

❮ Previous
Next ❯

Citations

Aug 21, 2021·Expert Review of Vaccines·Nan-Chang ChiuChien-Yu Lin

❮ Previous
Next ❯